Tumor immunology : immunotherapy and cancer vaccines

Contributors Series Editor's Preface Abbreviations 1. Introduction and historical perspectives Michael Browning and A. G. Dalgleish 2. The immunosurveillance of cancer: specific and non-specific mechanisms Richard G. Vile, Heung Chong and Sina Dorudi 3. Antigen processing and presentation Nicholas C. Testifo and Michael Wang 4. The role of the MHC class I in tumor immunity Michael Browning 5. Human tumor antigens recognized by Cytolytic T Lymphocytes Pierre G Coulie 6. Peptide-specific CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis J. M. Melief and W. Martin Kast 7. Cellular oncogenes for tumor immunity: immunotherapy Hans J. Strauss and A. Maria Dahl 8. Co-stimulatory molecules and their role in tumour immunity A. G. Dalgleish 9. The role of cytokines in tumour rejection Guido Forni and Robin Foa 10. Inhibition of nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines Dave S. B. Hoon, Takashi Morisaki and Richard Essner 11. Current concepts concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath 12. Immune responses to mucins Rosalind A. Graham and Joyce Taylor-Papadimitriou 13. Heat shock protein-peptide complexes: pan-valent vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod K. Srivastave 14. The potential of gene transfer to alter the immune response to tumors Bernard A. Fox and Gary J. Nabel 15. Applications of antibody gene technology Robert E. Hawkins and Kerry A. Chester Index.